{"acquired gene mutation": 1218.25, "alanine aminotransferase increased": 3.52, "aspartate aminotransferase increased": 2.71, "dermatitis acneiform": 58.68, "diarrhoea": 2.51, "disease progression": 10.08, "drug interaction": 2.68, "drug resistance": 184.44, "drug-induced liver injury": 8.75, "egfr gene mutation": 3098.4, "gene mutation": 71.74, "hepatic function abnormal": 8.72, "hepatotoxicity": 17.48, "interstitial lung disease": 20.74, "liver function test abnormal": 5.84, "liver injury": 8.6, "lung adenocarcinoma": 56.57, "lung adenocarcinoma stage iv": 500.68, "maligt neoplasm progression": 48.95, "maligt transformation": 1987.62, "metastases to bone": 39.38, "metastases to central nervous system": 140.33, "metastases to liver": 24.49, "metastases to lung": 38.12, "metastases to lymph nodes": 24.22, "metastases to meninges": 352.15, "myelosuppression": 2.78, "pancreatitis acute": 5.08, "paronychia": 91.39, "pleural effusion": 5.75, "rash": 3.17, "rash pruritic": 2.91, "rash pustular": 18.2, "respiratory failure": 3.31, "skin toxicity": 49.03, "small cell lung cancer": 243.01, "transaminases increased": 5.48}